Medtronic To Pay $55M In HeartWare Investor Suit
Device-giant Medtronic has agreed to pay $54.5m to settle a class-action suit filed by investors in HeartWare, which Medtronic bought in 2016. The plaintiffs say HeartWare misled investors about the safety of a miniaturized heart pump under development.
You may also be interested in...
Medtronic Ups Its Heart-Failure Competitive Strength With HeartWare Buy
The deal gives Medtronic its first ventricular-assist devices and gives struggling HeartWare a needed boost.
HeartWare Updates Status Of Battles On Several Fronts
HeartWare is counting on its established HVAD technology to carry it through a difficult period as it struggles to relaunch the clinical trial of the MVAD miniaturized ventricular assist device.
COVID-19 EUAs To Stay Active After Public Health Emergency Ends
Authorizations in place for diagnostics, personal protective equipment, and other products cleared for emergency use during the pandemic will remain in place until the potential for an outbreak no longer exists or products receive traditional clearances, according to a Federal Register notice issued by HHS this week.